Home > Boards > US OTC > Biotechs > Recro Pharma, Inc. (REPH)

$RPEH down 40% as if it were about

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
BiotechValues Member Profile
 
Followed By 340
Posts 10,238
Boards Moderated 2
Alias Born 06/23/07
160x600 placeholder
Recro to Present at Stephens Annual Investment Conference GlobeNewswire Inc. - 12/2/2021 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/19/2021 5:16:30 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 11/19/2021 4:16:25 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/16/2021 6:12:59 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/16/2021 6:10:53 AM
Recro Pharma EPS in-line, beats on revenue Seeking Alpha - 11/9/2021 4:42:18 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/9/2021 4:18:34 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/9/2021 4:11:52 PM
Recro Reports Third Quarter 2021 Financial Results GlobeNewswire Inc. - 11/9/2021 4:05:00 PM
Recro Pharma Q3 2021 Earnings Preview Seeking Alpha - 11/8/2021 5:35:17 PM
Recro to Report Financial Results for Third Quarter 2021 on November 9, 2021 GlobeNewswire Inc. - 11/2/2021 4:05:00 PM
Recro Enters Into Master Commercial Supply and Services Agreement With Otsuka GlobeNewswire Inc. - 10/27/2021 7:00:00 AM
Recro Awarded Development and Manufacturing Contract by National Institutes of Health (NIH) to Support Novel Nasal Spray Analgesic GlobeNewswire Inc. - 10/20/2021 7:00:00 AM
Recro Reports Inducement Grants For New Staff GlobeNewswire Inc. - 10/6/2021 7:00:00 AM
Recro Signs Renewable Energy Agreement With Georgia Power GlobeNewswire Inc. - 9/21/2021 7:00:00 AM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 9/10/2021 4:58:09 PM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 9/10/2021 4:20:17 PM
Recro and BioCorRx Expand Development and Manufacturing Relationship to Support BICX104, an Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder GlobeNewswire Inc. - 9/8/2021 7:00:00 AM
Recro and BioCorRx Expand Development and Manufacturing Relationship to Support BICX104, an Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder GlobeNewswire Inc. - 9/8/2021 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/23/2021 9:21:55 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/19/2021 9:02:29 AM
Recro to Host Webcast to Discuss Acquisition of San Diego-Based IRISYS GlobeNewswire Inc. - 8/17/2021 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/13/2021 5:23:18 PM
Recro Announces Acquisition of San Diego-based IRISYS, Creating Bi-Coastal, Full Service CDMO GlobeNewswire Inc. - 8/13/2021 8:50:00 AM
Recro Announces Entry Into Letter of Intent for Acquisition of a Full Service CDMO GlobeNewswire Inc. - 8/10/2021 7:00:00 AM
BiotechValues   Monday, 05/11/20 03:42:51 PM
Re: None
Post # of 79 
$RPEH down 40% as if it were about to declare BK.

Yet, 2020 guidance says:

"The Company expects its Operating Income to be in the range of $5 million to $9 million and Operating income, as adjusted* to be in the range of $13 million to $17 million. EBITDA, as adjusted (Historical CDMO) to be in the range of $33 million to $37 million and EBITDA, as adjusted (Standalone)* to be in the range of $26 million to $30 million."


Took a starter today. Might take a bit to recover but I can be patient.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences